QR kȏd

Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib

Spremljeno u:
Glavni autori: Christopher J. Fay, BA, Dorsa Moslehi, BA, Christopher Iriarte, MD, Timothy M. Dang, MD, Cesar A. Virgen, MD, PhD, Eleanor Russell-Goldman, MD, PhD, Nicole R. LeBoeuf, MD, MPH
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2023-09-01
Serija:JAAD Case Reports
Teme:
cutaneous Rosai-Dorfman disease
histiocytic disorders
MEK inhibitor
methotrexate
non-Langerhans cell histiocytosis
Rosai–Dorfman disease
Online pristup:http://www.sciencedirect.com/science/article/pii/S2352512623002357
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti